nodes	percent_of_prediction	percent_of_DWPC	metapath
Fexofenadine—SLCO1B3—Methotrexate—muscle cancer	0.269	0.272	CbGbCtD
Fexofenadine—SLCO1A2—Methotrexate—muscle cancer	0.166	0.168	CbGbCtD
Fexofenadine—SLCO1B1—Methotrexate—muscle cancer	0.157	0.158	CbGbCtD
Fexofenadine—ABCB1—Dactinomycin—muscle cancer	0.12	0.122	CbGbCtD
Fexofenadine—ABCB1—Vincristine—muscle cancer	0.0741	0.0749	CbGbCtD
Fexofenadine—ABCB1—Etoposide—muscle cancer	0.0679	0.0687	CbGbCtD
Fexofenadine—ABCB1—Doxorubicin—muscle cancer	0.0463	0.0468	CbGbCtD
Fexofenadine—ABCB1—Methotrexate—muscle cancer	0.0449	0.0454	CbGbCtD
Fexofenadine—CYP2D6—Doxorubicin—muscle cancer	0.0436	0.0441	CbGbCtD
Fexofenadine—Chest discomfort—Etoposide—muscle cancer	0.000316	0.0281	CcSEcCtD
Fexofenadine—Pain in extremity—Vincristine—muscle cancer	0.00025	0.0223	CcSEcCtD
Fexofenadine—Cardiac failure congestive—Etoposide—muscle cancer	0.000224	0.0199	CcSEcCtD
Fexofenadine—Otitis media—Doxorubicin—muscle cancer	0.000186	0.0165	CcSEcCtD
Fexofenadine—Flushing—Dactinomycin—muscle cancer	0.00018	0.016	CcSEcCtD
Fexofenadine—Viral infection—Doxorubicin—muscle cancer	0.00016	0.0143	CcSEcCtD
Fexofenadine—Back pain—Vincristine—muscle cancer	0.000146	0.013	CcSEcCtD
Fexofenadine—Myalgia—Dactinomycin—muscle cancer	0.000144	0.0128	CcSEcCtD
Fexofenadine—Agitation—Vincristine—muscle cancer	0.000139	0.0123	CcSEcCtD
Fexofenadine—Infection—Dactinomycin—muscle cancer	0.000137	0.0122	CcSEcCtD
Fexofenadine—Dry eye—Doxorubicin—muscle cancer	0.000134	0.0119	CcSEcCtD
Fexofenadine—Flushing—Etoposide—muscle cancer	0.00013	0.0116	CcSEcCtD
Fexofenadine—Myalgia—Vincristine—muscle cancer	0.000128	0.0114	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000125	0.0112	CcSEcCtD
Fexofenadine—Anaphylactic shock—Vincristine—muscle cancer	0.000123	0.0109	CcSEcCtD
Fexofenadine—Infection—Vincristine—muscle cancer	0.000122	0.0109	CcSEcCtD
Fexofenadine—Fatigue—Dactinomycin—muscle cancer	0.000119	0.0106	CcSEcCtD
Fexofenadine—Back pain—Etoposide—muscle cancer	0.000118	0.0105	CcSEcCtD
Fexofenadine—Pain—Dactinomycin—muscle cancer	0.000118	0.0105	CcSEcCtD
Fexofenadine—Cardiac failure congestive—Doxorubicin—muscle cancer	0.000116	0.0103	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000113	0.01	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000112	0.00997	CcSEcCtD
Fexofenadine—Increased appetite—Doxorubicin—muscle cancer	0.000112	0.00995	CcSEcCtD
Fexofenadine—Insomnia—Vincristine—muscle cancer	0.000111	0.00989	CcSEcCtD
Fexofenadine—Abdominal pain—Dactinomycin—muscle cancer	0.000109	0.00968	CcSEcCtD
Fexofenadine—Body temperature increased—Dactinomycin—muscle cancer	0.000109	0.00968	CcSEcCtD
Fexofenadine—Cough—Etoposide—muscle cancer	0.000107	0.00947	CcSEcCtD
Fexofenadine—Fatigue—Vincristine—muscle cancer	0.000106	0.00943	CcSEcCtD
Fexofenadine—Pain—Vincristine—muscle cancer	0.000105	0.00935	CcSEcCtD
Fexofenadine—Pain in extremity—Doxorubicin—muscle cancer	0.000105	0.00935	CcSEcCtD
Fexofenadine—Hypersensitivity—Dactinomycin—muscle cancer	0.000101	0.00902	CcSEcCtD
Fexofenadine—Abdominal discomfort—Methotrexate—muscle cancer	0.000101	0.00895	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Vincristine—muscle cancer	0.000101	0.00894	CcSEcCtD
Fexofenadine—Anaphylactic shock—Etoposide—muscle cancer	9.96e-05	0.00886	CcSEcCtD
Fexofenadine—Infection—Etoposide—muscle cancer	9.9e-05	0.0088	CcSEcCtD
Fexofenadine—Asthenia—Dactinomycin—muscle cancer	9.88e-05	0.00878	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Methotrexate—muscle cancer	9.75e-05	0.00867	CcSEcCtD
Fexofenadine—Tachycardia—Etoposide—muscle cancer	9.72e-05	0.00865	CcSEcCtD
Fexofenadine—Abdominal pain—Vincristine—muscle cancer	9.72e-05	0.00865	CcSEcCtD
Fexofenadine—Body temperature increased—Vincristine—muscle cancer	9.72e-05	0.00865	CcSEcCtD
Fexofenadine—Diarrhoea—Dactinomycin—muscle cancer	9.42e-05	0.00838	CcSEcCtD
Fexofenadine—Nasopharyngitis—Doxorubicin—muscle cancer	9.4e-05	0.00836	CcSEcCtD
Fexofenadine—Drowsiness—Methotrexate—muscle cancer	9.36e-05	0.00832	CcSEcCtD
Fexofenadine—Hypersensitivity—Vincristine—muscle cancer	9.06e-05	0.00806	CcSEcCtD
Fexofenadine—Dyspnoea—Etoposide—muscle cancer	8.88e-05	0.0079	CcSEcCtD
Fexofenadine—Somnolence—Etoposide—muscle cancer	8.86e-05	0.00788	CcSEcCtD
Fexofenadine—Epistaxis—Methotrexate—muscle cancer	8.83e-05	0.00785	CcSEcCtD
Fexofenadine—Asthenia—Vincristine—muscle cancer	8.83e-05	0.00785	CcSEcCtD
Fexofenadine—Vomiting—Dactinomycin—muscle cancer	8.75e-05	0.00778	CcSEcCtD
Fexofenadine—Rash—Dactinomycin—muscle cancer	8.68e-05	0.00772	CcSEcCtD
Fexofenadine—Fatigue—Etoposide—muscle cancer	8.59e-05	0.00764	CcSEcCtD
Fexofenadine—Pain—Etoposide—muscle cancer	8.52e-05	0.00758	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Doxorubicin—muscle cancer	8.45e-05	0.00751	CcSEcCtD
Fexofenadine—Diarrhoea—Vincristine—muscle cancer	8.42e-05	0.00748	CcSEcCtD
Fexofenadine—Pollakiuria—Doxorubicin—muscle cancer	8.4e-05	0.00747	CcSEcCtD
Fexofenadine—Nausea—Dactinomycin—muscle cancer	8.18e-05	0.00727	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Etoposide—muscle cancer	8.15e-05	0.00725	CcSEcCtD
Fexofenadine—Dizziness—Vincristine—muscle cancer	8.13e-05	0.00723	CcSEcCtD
Fexofenadine—Drowsiness—Doxorubicin—muscle cancer	8.1e-05	0.00721	CcSEcCtD
Fexofenadine—Urticaria—Etoposide—muscle cancer	7.92e-05	0.00704	CcSEcCtD
Fexofenadine—Body temperature increased—Etoposide—muscle cancer	7.88e-05	0.007	CcSEcCtD
Fexofenadine—Abdominal pain—Etoposide—muscle cancer	7.88e-05	0.007	CcSEcCtD
Fexofenadine—Vomiting—Vincristine—muscle cancer	7.82e-05	0.00696	CcSEcCtD
Fexofenadine—Rash—Vincristine—muscle cancer	7.76e-05	0.0069	CcSEcCtD
Fexofenadine—Dermatitis—Vincristine—muscle cancer	7.75e-05	0.00689	CcSEcCtD
Fexofenadine—Headache—Vincristine—muscle cancer	7.71e-05	0.00685	CcSEcCtD
Fexofenadine—Epistaxis—Doxorubicin—muscle cancer	7.64e-05	0.0068	CcSEcCtD
Fexofenadine—Sinusitis—Doxorubicin—muscle cancer	7.6e-05	0.00676	CcSEcCtD
Fexofenadine—Hypersensitivity—Etoposide—muscle cancer	7.34e-05	0.00653	CcSEcCtD
Fexofenadine—Nausea—Vincristine—muscle cancer	7.31e-05	0.0065	CcSEcCtD
Fexofenadine—Asthenia—Etoposide—muscle cancer	7.15e-05	0.00636	CcSEcCtD
Fexofenadine—Back pain—Methotrexate—muscle cancer	7.07e-05	0.00629	CcSEcCtD
Fexofenadine—Pruritus—Etoposide—muscle cancer	7.05e-05	0.00627	CcSEcCtD
Fexofenadine—Vision blurred—Methotrexate—muscle cancer	6.89e-05	0.00613	CcSEcCtD
Fexofenadine—Diarrhoea—Etoposide—muscle cancer	6.82e-05	0.00606	CcSEcCtD
Fexofenadine—Flushing—Doxorubicin—muscle cancer	6.75e-05	0.006	CcSEcCtD
Fexofenadine—Dizziness—Etoposide—muscle cancer	6.59e-05	0.00586	CcSEcCtD
Fexofenadine—Cough—Methotrexate—muscle cancer	6.38e-05	0.00568	CcSEcCtD
Fexofenadine—Vomiting—Etoposide—muscle cancer	6.34e-05	0.00563	CcSEcCtD
Fexofenadine—Rash—Etoposide—muscle cancer	6.28e-05	0.00559	CcSEcCtD
Fexofenadine—Dermatitis—Etoposide—muscle cancer	6.28e-05	0.00558	CcSEcCtD
Fexofenadine—Headache—Etoposide—muscle cancer	6.24e-05	0.00555	CcSEcCtD
Fexofenadine—Flatulence—Doxorubicin—muscle cancer	6.24e-05	0.00555	CcSEcCtD
Fexofenadine—Myalgia—Methotrexate—muscle cancer	6.23e-05	0.00554	CcSEcCtD
Fexofenadine—Tension—Doxorubicin—muscle cancer	6.21e-05	0.00553	CcSEcCtD
Fexofenadine—Nervousness—Doxorubicin—muscle cancer	6.15e-05	0.00547	CcSEcCtD
Fexofenadine—Back pain—Doxorubicin—muscle cancer	6.13e-05	0.00545	CcSEcCtD
Fexofenadine—Anaphylactic shock—Methotrexate—muscle cancer	5.97e-05	0.00531	CcSEcCtD
Fexofenadine—Vision blurred—Doxorubicin—muscle cancer	5.97e-05	0.00531	CcSEcCtD
Fexofenadine—Infection—Methotrexate—muscle cancer	5.93e-05	0.00527	CcSEcCtD
Fexofenadine—Nausea—Etoposide—muscle cancer	5.92e-05	0.00526	CcSEcCtD
Fexofenadine—Agitation—Doxorubicin—muscle cancer	5.82e-05	0.00518	CcSEcCtD
Fexofenadine—Palpitations—Doxorubicin—muscle cancer	5.6e-05	0.00498	CcSEcCtD
Fexofenadine—Cough—Doxorubicin—muscle cancer	5.53e-05	0.00491	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Methotrexate—muscle cancer	5.44e-05	0.00484	CcSEcCtD
Fexofenadine—Insomnia—Methotrexate—muscle cancer	5.4e-05	0.0048	CcSEcCtD
Fexofenadine—Myalgia—Doxorubicin—muscle cancer	5.39e-05	0.00479	CcSEcCtD
Fexofenadine—Dyspnoea—Methotrexate—muscle cancer	5.32e-05	0.00473	CcSEcCtD
Fexofenadine—Somnolence—Methotrexate—muscle cancer	5.31e-05	0.00472	CcSEcCtD
Fexofenadine—Dry mouth—Doxorubicin—muscle cancer	5.27e-05	0.00469	CcSEcCtD
Fexofenadine—Dyspepsia—Methotrexate—muscle cancer	5.25e-05	0.00467	CcSEcCtD
Fexofenadine—Anaphylactic shock—Doxorubicin—muscle cancer	5.17e-05	0.0046	CcSEcCtD
Fexofenadine—Fatigue—Methotrexate—muscle cancer	5.15e-05	0.00458	CcSEcCtD
Fexofenadine—Infection—Doxorubicin—muscle cancer	5.13e-05	0.00457	CcSEcCtD
Fexofenadine—Pain—Methotrexate—muscle cancer	5.1e-05	0.00454	CcSEcCtD
Fexofenadine—Tachycardia—Doxorubicin—muscle cancer	5.04e-05	0.00449	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Methotrexate—muscle cancer	4.88e-05	0.00434	CcSEcCtD
Fexofenadine—Urticaria—Methotrexate—muscle cancer	4.74e-05	0.00422	CcSEcCtD
Fexofenadine—Body temperature increased—Methotrexate—muscle cancer	4.72e-05	0.0042	CcSEcCtD
Fexofenadine—Abdominal pain—Methotrexate—muscle cancer	4.72e-05	0.0042	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	4.71e-05	0.00419	CcSEcCtD
Fexofenadine—Insomnia—Doxorubicin—muscle cancer	4.67e-05	0.00416	CcSEcCtD
Fexofenadine—Dyspnoea—Doxorubicin—muscle cancer	4.61e-05	0.0041	CcSEcCtD
Fexofenadine—Somnolence—Doxorubicin—muscle cancer	4.59e-05	0.00409	CcSEcCtD
Fexofenadine—Dyspepsia—Doxorubicin—muscle cancer	4.55e-05	0.00405	CcSEcCtD
Fexofenadine—Fatigue—Doxorubicin—muscle cancer	4.46e-05	0.00396	CcSEcCtD
Fexofenadine—Pain—Doxorubicin—muscle cancer	4.42e-05	0.00393	CcSEcCtD
Fexofenadine—Hypersensitivity—Methotrexate—muscle cancer	4.4e-05	0.00391	CcSEcCtD
Fexofenadine—Asthenia—Methotrexate—muscle cancer	4.28e-05	0.00381	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Doxorubicin—muscle cancer	4.23e-05	0.00376	CcSEcCtD
Fexofenadine—Pruritus—Methotrexate—muscle cancer	4.22e-05	0.00376	CcSEcCtD
Fexofenadine—Urticaria—Doxorubicin—muscle cancer	4.11e-05	0.00365	CcSEcCtD
Fexofenadine—Abdominal pain—Doxorubicin—muscle cancer	4.09e-05	0.00363	CcSEcCtD
Fexofenadine—Body temperature increased—Doxorubicin—muscle cancer	4.09e-05	0.00363	CcSEcCtD
Fexofenadine—Diarrhoea—Methotrexate—muscle cancer	4.08e-05	0.00363	CcSEcCtD
Fexofenadine—Dizziness—Methotrexate—muscle cancer	3.95e-05	0.00351	CcSEcCtD
Fexofenadine—Hypersensitivity—Doxorubicin—muscle cancer	3.81e-05	0.00339	CcSEcCtD
Fexofenadine—Vomiting—Methotrexate—muscle cancer	3.79e-05	0.00337	CcSEcCtD
Fexofenadine—Rash—Methotrexate—muscle cancer	3.76e-05	0.00335	CcSEcCtD
Fexofenadine—Dermatitis—Methotrexate—muscle cancer	3.76e-05	0.00334	CcSEcCtD
Fexofenadine—Headache—Methotrexate—muscle cancer	3.74e-05	0.00333	CcSEcCtD
Fexofenadine—Asthenia—Doxorubicin—muscle cancer	3.71e-05	0.0033	CcSEcCtD
Fexofenadine—Pruritus—Doxorubicin—muscle cancer	3.66e-05	0.00325	CcSEcCtD
Fexofenadine—Nausea—Methotrexate—muscle cancer	3.55e-05	0.00315	CcSEcCtD
Fexofenadine—Diarrhoea—Doxorubicin—muscle cancer	3.54e-05	0.00314	CcSEcCtD
Fexofenadine—Dizziness—Doxorubicin—muscle cancer	3.42e-05	0.00304	CcSEcCtD
Fexofenadine—Vomiting—Doxorubicin—muscle cancer	3.29e-05	0.00292	CcSEcCtD
Fexofenadine—Rash—Doxorubicin—muscle cancer	3.26e-05	0.0029	CcSEcCtD
Fexofenadine—Dermatitis—Doxorubicin—muscle cancer	3.26e-05	0.0029	CcSEcCtD
Fexofenadine—Headache—Doxorubicin—muscle cancer	3.24e-05	0.00288	CcSEcCtD
Fexofenadine—Nausea—Doxorubicin—muscle cancer	3.07e-05	0.00273	CcSEcCtD
